IMPLANT SITE HYPERAESTHESIA

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting IMPLANT SITE HYPERAESTHESIA:

# Drug Count
0 ETONOGESTREL 9
1 BACLOFEN INJECTION 1
See all common drugs associated with IMPLANT SITE HYPERAESTHESIA

IMPLANT SITE HYPERAESTHESIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACLOFEN INJECTION 1 0.0003
1 ETONOGESTREL 9 0.0002
See all drugs enriched for association with IMPLANT SITE HYPERAESTHESIA

These drug classes are most commonly taken by patients reporting IMPLANT SITE HYPERAESTHESIA:

# Drug class Count
0 Progestin [EPC] 9
1 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1
See all common drug classes associated with IMPLANT SITE HYPERAESTHESIA

IMPLANT SITE HYPERAESTHESIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 9 0.0000
1 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE HYPERAESTHESIA